Literature DB >> 6822727

Effect of various oral dose levels of a trimethoprim/sulphadiazine mixture on Bordetella bronchiseptica infection and on the proliferation of trimethoprim-resistant faecal coliforms in pigs.

L Dassanayake, G White.   

Abstract

When a 1:5 mixture of trimethoprim (TMP) and sulphadiazine was fed to pigs intra-nasally infected with bordetella bronchiseptica, 10 mg/kg/day was shown to be highly effective in suppressing the organism. This dose level had little effect on numbers of TMP-resistant coliforms in faeces, but oral doses of 30 mg/kg/day eventually selected a resistant population. It is suggested that the proliferation of resistant coliforms would be minimized by administration of the lowest oral dose rates of antibacterial drugs compatible with efficacy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822727      PMCID: PMC2134189          DOI: 10.1017/s0022172400063816

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  5 in total

1.  Animal model for determining the no-effect level of an antimicrobial drug on drug resistance in the lactose-fermenting enteric flora.

Authors:  L D Rollins; S A Gaines; D W Pocurull; H D Mercer
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

2.  Trimethoprim resistance conferred by W plasmids in Enterobacteriaceae.

Authors:  N Datta; R W Hedges
Journal:  J Gen Microbiol       Date:  1972-09

3.  Treatment of experimental Bordetella bronchiseptica infection in young pigs with potentiated sulphonamide in the drinking water.

Authors:  C J Giles; I M Smith; A J Baskerville; J Oliphant
Journal:  Vet Rec       Date:  1981-02-14       Impact factor: 2.695

4.  Escherichia coli resistant to tetracyclines and to other antibiotics in the faeces of U.K. chickens and pigs in 1980.

Authors:  H W Smith; M A Lovell
Journal:  J Hyg (Lond)       Date:  1981-12

5.  Canine bordetellosis: chemotherapy using a sulphadiazine-trimethoprim combination.

Authors:  I A McCandlish; H Thompson
Journal:  Vet Rec       Date:  1979-07-21       Impact factor: 2.695

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.